150 related articles for article (PubMed ID: 396385)
1. The role of renal prostaglandin E and kallikrein in pathogenesis of essential hypertension.
Abe K; Yasujima M; Sakurai Y; Chiba S; Itoh T; Imai Y; Sato M; Haruyama T; Omata K; Goto T; Sato K; Hiwatari M; Otsuka Y; Yoshinaga K
Jpn Circ J; 1979 Dec; 43(12):1105-16. PubMed ID: 396385
[No Abstract] [Full Text] [Related]
2. Renal kallikrein-kinin system and prostaglandin in hypertension: their relation to renin-angiotensin-aldosterone system.
Abe K; Yasujima M; Chiba S; Sato M; Irokawa N; Imai Y; Yoshinaga K
Adv Exp Med Biol; 1979; 120B():487-501. PubMed ID: 517244
[TBL] [Abstract][Full Text] [Related]
3. Renal kallikrein-kinin: its relation to renal prostaglandins and renin-angiotensin-aldosterone in man.
Abe K; Sato M; Imai Y; Haruyama T; Sato K; Hiwatari M; Kasai Y; Yoshinaga K
Kidney Int; 1981 Jun; 19(6):869-80. PubMed ID: 7021957
[No Abstract] [Full Text] [Related]
4. The role of intrarenal vasoactive substances in the pathogenesis of essential hypertension.
Abe K; Yasujima M; Irokawa N; Seino M; Chiba S; Sakurai Y; Sato M; Imai Y; Saito K; Ito T; Haruyama T; Otsuka Y; Yoshinaga K
Clin Sci Mol Med Suppl; 1978 Dec; 4():363s-366s. PubMed ID: 282087
[No Abstract] [Full Text] [Related]
5. Bartter's syndrome: effect of indomethacin on prostaglandins, urinary kallikrein, renin-angiotensin-aldosterone system, and the response to angiotensin II antagonist.
Sasaki H; Kawasaki T; Okumura M; Asano T; Abe K; Arakawa K
Endocrinol Jpn; 1980 Aug; 27(4):417-29. PubMed ID: 7007031
[No Abstract] [Full Text] [Related]
6. [Studies on renal prostaglandin E in essential hypertension: relationships among urinary prostaglandin E, sodium balance, renin-angiotensin-aldosterone system and renal kallikrein-kinin system (author's transl)].
Abe K; Yasujima M; Chiba S; Sato M; Irokawa N; Seino M; Sakurai Y; Saito K; Kusaka T; Imai Y; Ito T; Ritsu K; Haruyama T; Otsuka Y; Yoshinaga K
Nihon Naika Gakkai Zasshi; 1978 Dec; 67(12):1537-45. PubMed ID: 744897
[No Abstract] [Full Text] [Related]
7. The role of renal kallikrein and prostaglandin in the control of renin release.
Suzuki S; Kobayashi M; Hashiba K
Jpn Heart J; 1986 Jan; 27(1):83-93. PubMed ID: 2425102
[TBL] [Abstract][Full Text] [Related]
8. Effects of indomethacin on plasma renin activity, plasma aldosterone concentration, urinary prostaglandin E excretion and blood pressure in patients with essential hypertension.
Yasujima M; Abe K; Chiba S; Sato M; Irokawa N; Imai Y; Saito K; Sakurai Y; Ito T; Ritsu K; Haruyama T; Otsuka Y; Yoshinaga K
Tohoku J Exp Med; 1979 May; 128(1):31-7. PubMed ID: 452004
[No Abstract] [Full Text] [Related]
9. Effect of triamterene on urinary excretion of immunoreactive prostaglandin E in essential hypertension.
Chiba S; Abe K; Yasujima M; Irokawa N; Saito K; Sakurai Y; Ito T; Sato M; Otsuka Y; Yoshinaga K
Tohoku J Exp Med; 1979 Nov; 129(3):249-56. PubMed ID: 524352
[TBL] [Abstract][Full Text] [Related]
10. Bartter's syndrome: urinary prostaglandin E-like material and kallikrein; indomethacin effects.
Halushka PV; Wohltmann H; Privitera PJ; Hurwitz G; Margolius HS
Ann Intern Med; 1977 Sep; 87(3):281-6. PubMed ID: 900671
[TBL] [Abstract][Full Text] [Related]
11. Studies on essential hypertension with suppressed plasma renin activity: sodium excretion pattern on salt restriction and effects of spironolactone on blood pressure and plasma renin activity.
Uchida K; Morimoto S; Takeda R; Murakami M
Jpn Circ J; 1972 Dec; 36(12):1301-11. PubMed ID: 4679217
[No Abstract] [Full Text] [Related]
12. Effect of furosemide on urinary kallikrein excretion in patients with essential hypertension.
Seino M; Abe K; Irokawa N; Ito T; Yasujima M; Sakurai Y; Chiba S; Saito K; Ritz K; Kusaka T; Miyazaki S; Yoshinaga K
Tohoku J Exp Med; 1978 Mar; 124(3):197-203. PubMed ID: 635897
[TBL] [Abstract][Full Text] [Related]
13. [Pathogenesis of essential hypertension with suppressed plasma renin activity].
Uchida K
Nihon Naibunpi Gakkai Zasshi; 1972 Dec; 48(9):674-84. PubMed ID: 4675750
[No Abstract] [Full Text] [Related]
14. Implication of renal prostaglandin E in urinary sodium excretion.
Yasujima M; Abe K; Chiba S; Sato M; Irokawa N; Seino M; Imai Y; Saito K; Sakurai Y; Ito T; Haruyama T; Ritsu K; Yoshinaga K
Jpn Circ J; 1978 May; 42(5):565-9. PubMed ID: 702774
[TBL] [Abstract][Full Text] [Related]
15. Urinary prostaglandin E2 and kallikrein excretion in glucocorticoid hypertension in rats.
Handa M; Kondo K; Suzuki H; Saruta T
Clin Sci (Lond); 1983 Jul; 65(1):37-42. PubMed ID: 6342908
[TBL] [Abstract][Full Text] [Related]
16. Urinary kallikrein, aldosterone, prostaglandin E2, sodium, potassium, and urinary volume in normal man-interrelations and day to day variation.
Ohman KP; Karlberg BE
Acta Med Scand Suppl; 1983; 677():30-5. PubMed ID: 6584001
[No Abstract] [Full Text] [Related]
17. Studies of the renal vasoactive systems in hyporeninemic hypoaldosteronism.
Hahn JA; Zipser RD; Barg A; Stone RA; Zia PK; Hsueh WA; Horton R
Prostaglandins Med; 1981 Jun; 6(6):549-56. PubMed ID: 6267637
[TBL] [Abstract][Full Text] [Related]
18. Suppression of plasma renin activity by indomethacin in man.
Frölich JC; Hollifield JW; Dormois JC; Frölich BL; Seyberth H; Michelakis AM; Oates JA
Circ Res; 1976 Sep; 39(3):447-52. PubMed ID: 821675
[TBL] [Abstract][Full Text] [Related]
19. The kallikrein-kinin system and prostaglandins in the kidney: their relation to forosemide-induced diuresis and to the renin-angiotensin-aldosterone system in man.
Abe K; Irokawa N; Yasujima M; Seino M; Chiba S; Sakurai Y; Yoshinaga K; Saito T
Circ Res; 1978 Aug; 43(2):254-60. PubMed ID: 668057
[No Abstract] [Full Text] [Related]
20. Hypotensive and natriuretic effects of nifedipine in essential hypertension. Role of renal kallikrein-kinin-prostaglandin and renin-angiotensin-aldosterone systems.
Tsunoda K; Abe K; Omata K; Kudo K; Sato M; Kohzuki M; Tanno M; Seino M; Yasujima M; Yoshinaga K
J Clin Hypertens; 1986 Sep; 2(3):263-70. PubMed ID: 3640807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
